Immunoassay analyzers are critical tools in laboratories to perform biochemical tests that measure specific proteins or other substances through their properties as antigens or antibodies. A recent market report from VPGMarketResearch.com predicts that the immunodiagnostics marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products such as specimen preparation devices, controls, and calibrators. Clinical chemistry and immunodiagnostic markets are undergoing significant transformation, mainly due to -
- New and more stringent regulations
- Advances in diagnostic technologies
- System engineering
- Automation, and IT
- Intensifying competition
The report explores future market trends, forecasts specimen, test and sales volume, estimates sales and market shares of key suppliers in major countries, compares features of leading analyzers, profiles key competitors, and identifies specific product and marketing opportunities for reagent and instrument suppliers. Major countries assessed include Canada, Mexico, and the USA.
Individual tests analyzed in the report include more than 100 clinical chemistry, therapeutic drug monitoring (TDM), endocrine function, tumor markers and special chemistry, immunoproteins and drugs of abuse assays.
The report also includes strategic assessments of major suppliers and emerging market entrants including Abbott, Agilent Technologies, Beckman Coulter/Danahe, Ortho-Clinical Diagnostics, Quest Diagnostics, Roche, Siemens, Sysmex, Thermo Fisher/Affymetrix and others.